| Cat. No. |
Size |
Price |
Figures |
RP10131-0.5 mg
| 0.5 mg | $ 80.75 | HPLC: 20080527014751 (PDF) MS: 20080527014850 (PDF) MSDS: 20080710020920 (PDF)
References:
- Jung HJ, et al. Biological activity of Tat (47-58) peptide on human pathogenic fungi. Biochem. Biophys. Res. Commun. Jun 2006; 345(1): 222-228.
- Barnett EM, et al. Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Invest. Ophthalmol. Vis. Sci. Jun 2006; 47(6): 2589-2595.
|
|---|
| Full Name | |
Sequence (one-letter code) |
YGRKKRRQRRRGYGRKKRRQRRRG |
Sequence (three-letter code) | {TYR}{GLY}{ARG}{LYS}{LYS}{ARG}{ARG}{GLN}{ARG}{ARG} {ARG}{GLY}{TYR}{GLY}{ARG}{LYS}{LYS}{ARG}{ARG}{GLN} {ARG}{ARG}{ARG}{GLY} |
| Description | The HIV Tat-derived peptide is a small basic peptide that has been successfully shown to deliver a large variety of cargoes, from small particles to proteins, peptides and nucleic acids. The 'transduction domain' or region conveying the cell penetrating properties appears to be confined to a small (9 amino acids) stretch of basic amino acids, with the sequence RKKRRQRRR. |
|---|
| Formula | C132H240N66O29 |
| M.W. | 3215.8 |
| Purity | > 95% |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |